Bcl-xL Cancer Research Results
Bcl-xL, Bcl-xL: Click to Expand ⟱
| Source: |
| Type: pro-survival proteins |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL.
BCL-XL overexpressing cells exhibited higher tumors sphere formation capacity and expressed higher levels of some stem cell markers, supporting the concept that BCL-XL plays essential roles in the maintenance of cancer stem cell phenotype.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
TumCP↓, TumMeta↓, p‑STAT3↓, JAK2↓, cSrc↓, JNK↑, p38↑, ERK↑, eff↓, ROS↑, cl‑PARP↑, TumCCA↑, Casp8↑, Casp9↑, Casp3↑, eff↑, Bcl-2↑, Bcl-xL↓, survivin↓, MMP9↓, COX2/PTGS2↓, IAP1↓, Dose?,
Bcl-2↓, Bcl-xL↓, Mcl-1↓, NOXA↑, PUMA↑, Dose↝, eff↓,
| - |
in-vitro, |
NSCLC, |
A549 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
tumCV↓, TumCG↓, TumCCA↑, MDM2↓, CycB/CCNB1↓, cDC2↓, CDC25↓, Casp3↑, PARP↑, ER Stress↑, p‑eIF2α↑, ATF4↑, TumCP↓, selectivity↑, Bcl-xL↓, Bcl-2↓,
Bcl-xL↓, Mcl-1↓, TumCP↓, STAT3↑, TumCP?,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
CDC25↓, 1,
Cell Death(tgid=5) ⓘ
Bcl-2↓, 2, Bcl-2↑, 1, Bcl-xL↓, 4, Casp3↑, 2, Casp8↑, 1, Casp9↑, 1, IAP1↓, 1, JNK↑, 1, Mcl-1↓, 2, MDM2↓, 1, NOXA↑, 1, p38↑, 1, PUMA↑, 1, survivin↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
cSrc↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
p‑eIF2α↑, 1, ER Stress↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PARP↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CycB/CCNB1↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
cDC2↓, 1, ERK↑, 1, STAT3↑, 1, p‑STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
MMP9↓, 1, TumCP?, 1, TumCP↓, 3, TumMeta↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
ATF4↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, JAK2↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose?, 1, Dose↝, 1, eff↓, 2, eff↑, 1, selectivity↑, 1,
Total Targets: 41
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-xL, Bcl-xL
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:28 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page